RAC media coverage, page-1908

1. I asked chatGPT for some questions to ask ( I'm not smart enough to come up with my own)
   I think most of these have been asked/answered previously.
   
   
   Overview of the Drug:

   • Can you provide a overview of the drug, including its mechanism of action, unique features, and any advantages over existing treatments?

2. Clinical Trial Progress:

   • What is the current status of the drug's clinical trials, and can you share any recent developments or milestones achieved?
   • Are there any upcoming catalysts or events related to the clinical trials that investors should be aware of?

3. Reformulation and Additional Uses:

   • How does the reformulation of the drug enhance its usability and effectiveness?
   • Can you discuss the potential of the drug for cardio protection and any other applications being explored?

4. Market Potential:

   • What is the estimated market size for the reformulated drug, and how does the company plan to capture a significant share of that market?
   • Are there any partnerships or collaborations in place to facilitate market penetration?

5. Regulatory Pathway:

   • Can you outline the regulatory pathway for the drug's approval? Are there any potential challenges or risks associated with the regulatory process?

6. Commercialization Plans:

   • What are the company's plans for commercializing the drug once it receives regulatory approval?
   • Can you provide a timeline for when the drug is expected to reach the market?

7. Competitive Landscape:

   • How does the drug compare to existing treatments in terms of efficacy, safety, and cost-effectiveness?
   • What sets the company apart from competitors working on similar therapies?

8. Financial Viability:

   • How is the company funded, and what is its financial strategy to support the drug's development and commercialization?
   • Can you discuss the company's financial stability and its ability to navigate potential challenges?

9. Intellectual Property Protection:

   • What measures has the company taken to protect its intellectual property related to the drug?
   • Are there any concerns regarding potential patent challenges or infringements?

10. Risks and Mitigation Strategies:

    • What are the main risks associated with the development and commercialization of the drug, and how does the company plan to mitigate these risks?
    • How does the management team plan to address unforeseen challenges that may arise during the drug development process?